Matthew Boeckman, MD
Pain Medicine · del City, OKNPI 1861641961
Payments from drug & device makers
Across 496 payments — averaging $12.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Collegium Pharmaceutical, Inc.$730
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$567
- Biodelivery Sciences International, Inc.$358
- Pfizer$306
- Amgen$276
- plus $2K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 182 | $2,034 |
| Collegium Pharmaceutical, Inc. | 58 | $730 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $567 |
| Biodelivery Sciences International, Inc. | 43 | $358 |
| Pfizer | 38 | $306 |
| Amgen(2 entities) | 29 | $276 |
| Merck | 17 | $240 |
| Scilex Pharmaceuticals Inc. | 14 | $218 |
| AstraZeneca | 15 | $200 |
| Eisai Inc. | 16 | $196 |
| Boston Scientific | 3 | $132 |
| Redhill Biopharma Inc. | 7 | $116 |
| Daiichi Sankyo Inc. | 6 | $109 |
| Shionogi Inc | 4 | $89 |
| Forte Bio-pharma LLC | 1 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| IBSA Pharma Inc. | 3 | $41 |
| Nevro Corp. | 2 | $39 |
| Sentynl Therapeutics, Inc. | 3 | $39 |
| Vertex | 2 | $38 |
| Almatica Pharma LLC | 2 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Valinor Pharma, LLC | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 2 | $17 |
| Medtronic | 1 | $16 |
How this compares
$5,965 in reported general payments places this provider in the 65th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in del City
- Sailesh ArulkumarOklahoma City$257K
- Emily PollardOklahoma City$134K
- Rafael JustizOklahoma City$51K
- James StephensNorman$39K
- Tyler PhillipsOklahoma City$36K
- Jeffrey MillerMoore$33K
- Nevinson SamEdmond$27K
- John NelsonOklahoma City$26K
- Bruce MackeyEdmond$14K
- Brian TorgersonTulsa$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.